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The diagnosis of membranoproliferative glomerulonephritis
(MPGN) has recently undergone change from an electron
microscopy-based classification scheme to one based largely
on immunofluorescence findings. This change is due to the
recognition that many of these cases are driven by
abnormalities of the alternative complement cascade,
resulting in the concept of C3 glomerulopathy. Here we
reviewed our case files to identify those with an MPGN
pattern that show false negative staining for monoclonal
immunoglobulins by routine immunofluorescence.
Monoclonal immunoglobulin deposits were unmasked by
performing immunofluorescence on formalin-fixed paraffin
embedded tissue after protease digestion. Clinico-
pathological details of 16 such cases with a mean serum
creatinine of 2.7mg/dl and mean 24 h proteinuria of 7.1 g
were then determined. Hypocomplementemia was present in
two-thirds of patients. Fourteen patients had a paraprotein
on serum immunofixation, all of which matched the biopsy
immunofluorescence staining pattern. Bone marrow biopsy
showed plasma cell dyscrasia or B-cell lymphoproliferative
disorder in 13 patients. Ten of these patients had findings on
biopsy most consistent with C3 glomerulonephritis prior to
performing paraffin immunofluorescence. Thus a high index
of suspicion is necessary to avoid misdiagnosis in these cases,
as many would have been mistakenly diagnosed as
C3 glomerulopathy or unclassified MPGN if paraffin
immunofluorescence was not performed.
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Glomerular involvement is not uncommonly present in
patients with paraproteinemia. The paraprotein-associated
glomerulopathies are classified according to the findings on
renal biopsy utilizing light, immunofluorescence (IF), and
electron microscopy in combination with the clinical in-
formation. Glomerular disorders in this category include
immunoglobulin (Ig)-related amyloidosis, immunotactoid
GN, type 1 cryoglobulinemic GN, monoclonal Ig deposition
disease, proliferative GN with monoclonal Ig deposits, and C3
glomerulopathy with monoclonal gammopathy.1 These cases
commonly fall into the category of monoclonal gammopathy
of renal significance when the associated hematological
process does not meet diagnostic criteria for overt multiple
myeloma or B-cell lymphoma.2 Even in the lack of a
diagnostic hematological process, the monoclonal Ig can have
serious renal consequences and treatment of the underlying
clonal process is frequently warranted.3
It has recently been reported that Ig proteins occasionally
show false negative staining by routine IF.4,5 These deposits
can be ‘unmasked’ by performing IF on the formalin-fixed
paraffin-embedded tissue after protease digestion (paraffin IF).
Applying this technique to cases that show a membranopro-
liferative glomerulonephritis (MPGN) pattern has enabled this
case series detailing the first clinicopathological description of
glomerulopathy with an MPGN pattern by light microscopy
and masked monotypic Ig deposits by IF. All these patients
had an associated underlying clonal hematological disorder
and many of them would have been misdiagnosed as C3
glomerulopathy if paraffin IF was not performed and the
masked Igs detected.
RESULTS
The Nephropath renal biopsy database was reviewed
from 1 August 2013 to 1 December 2014 for cases with an
MPGN pattern by light microscopy that showed ‘masked’
monotypic Ig deposits on IF (little to no staining for
Igs by routine IF and positive Ig staining on paraffin IF with
light chain restriction; Figure 1). Nine cases were identified
who fulfilled these criteria and were included in this series.
During this same time period, there were also six cases of true
C3 GN in adults aged 440 years (evidence of MPGN with
C3-only staining who did not show Ig unmasking on
paraffin IF).
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© 2015 International Society of Nephrology
Correspondence: Christopher P. Larsen, Nephropath, 10180 Executive Center
Drive, Suite 100, Little Rock, Arkansas 72211, USA.
E-mail: Chris.larsen@nephropath.com
Received 13 February 2015; revised 6 May 2015; accepted 14 May 2015;
published online 8 July 2015
Kidney International (2015) 88, 867–873 867
The renal biopsy database (from January 2000 to January
2015) of the division of Anatomic Pathology at Mayo Clinic
was searched for patients with a known monoclonal
gammopathy who had a kidney biopsy showing C3-only or
GN with negative glomerular staining for IgG, IgM, IgA,
kappa, lambda and C3 by routine IF. Twenty-six cases were
identified who fulfilled these criteria, of which 21 had residual
paraffin tissue to undergo paraffin IF, including 11 cases of C3
GN, 6 dense deposit disease (DDD), and 4 unclassified
MPGN/cryoglobulinemic GN cases. Paraffin IF identified
7 (33%) cases (4 of the 11 C3 GN cases and 3 of the 4
unclassified MPGN/cryoglobulinemic GN cases) with positive
staining for Igs (all monoclonal) while the remaining 14
(67%) cases (7 of the C3 GN cases, all 6 DDD cases, 1 of the 4
unclassified MPGN/cryoglobulinemic GN cases) were nega-
tive for Igs.
Clinical data around the time of biopsy is presented in
Table 1. A total of 16 patients were identified who met
inclusion criteria for the study, including 9 cases from Nephro-
path and 7 cases from Mayo Clinic. The cohort consisted of 9
females and 7 males with a mean age of 61.6 years at the time
of biopsy. The vast majority of patients presented with renal
insufficiency, proteinuria, and hematuria. Serum creatinine was
elevated in 14 of the 16 patients (88%) with a mean value of
2.7mg/dl. All patients had proteinuria with a mean value of 7.1
g per 24 h and 13 of the 16 patients met criteria for full
nephrotic syndrome. Hematuria was present in all 15 patients
with this result available. Testing for serum C3 and C4 was
performed in 15 patients: 10 (67%) had hypocomplementemia,
including 5 with low C3 only, 2 with low C4 only, and 3 with
low C3 and C4, while the remaining 5 patients had normal C3
and C4. A single patient had a weakly positive antinuclear
antibody with a negative double-stranded DNA. The remaining
patients were antinuclear antibody negative. Antineutrophil
cytoplasmic antibody was negative in all the 13 patients tested.
All patients were negative for hepatitis B and C virus. A
cryoglobulin test was positive in 2 (13%) patients.
Fourteen (88%) patients had a paraprotein on serum
protein electrophoresis/immunofixation. This paraprotein
matched that of biopsy IF staining pattern in 13 cases while
in 1 case the immunofixation result was not known (see
Table 1). The remaining 2 (12%) patients had negative serum
immunofixation but both had evidence of a clonal B-cell
population on bone marrow biopsy. Bone marrow biopsy was
abnormal in 13 (81%) patients. This includes 9 patients
diagnosed with plasma cell dyscrasia, including 4 with multiple
myeloma and 5 patients with small clonal plasma cell
populations (⩽10%). Four patients were diagnosed with clonal
B-cell populations, including two with lymphoplasmacytic
lymphoma, one with chronic lymphocytic lymphoma, and one
with a small clonal low grade B-cell population. Two patients
did not have evidence of clonal hematological processes on
bone marrow biopsy but did have a positive paraprotein by
serum protein electrophoresis/immunofixation.
Histopathological findings are presented in Table 2. All
cases had an MPGN pattern of glomerular injury by light
microscopy. There were four cases with crescent formation,
all of which were focal. Ten cases had findings most
consistent with C3 GN based on the routine IF. In five
additional cases, the MPGN was unclassified because of the
negative routine IF staining for Igs and complement. Two of
these cases (#10 and #12) had light and electron microscopic
features suggestive of cryoglobulinemic GN, including
intracapillary protein thrombi, phagocytized deposits within
glomerular macrophages (Figure 2), focal deposits with
substructure, and in one case protein thrombi in vessels.
Serum cryoglobulin test was positive in the past in one of
these two patients (#10) and was negative in the other patient.
The ‘masked’ deposits were positive for IgG kappa in 12 cases,
IgG lambda in 2 cases, IgM lambda in 1 case, and IgM kappa
in 1 case. IF staining of the fresh tissue for IgG subtypes 1–4
was completely negative in all nine cases it was performed in.
By electron microscopy, all cases had deposits in the
subendothelial space and 12 also had mesangial deposits. Six
cases had evidence of subepithelial deposits and 5 cases
5 µm
Figure 1 | Light and immunofluorescence microscopic findings
in a case of membranoproliferative glomerulonephritis with
masked immunoglobulin G (IgG) kappa deposits (patient 2).
(a) Glomerulus with mesangial expansion, endocapillary
hypercellularity, and extensive basement membrane duplication
(Jones methenamine silver; original magnification × 400). (b) Positive
IgG staining within a glomerulus in the paraffin-embedded tissue
after protease digestion (direct immunofluorescence). (c) Kappa was
positive while (d) lambda was negative within glomeruli by paraffin
immunofluorescence (direct immunofluorescence). (e) The C3
was the dominant stain in glomeruli by routine immunofluorescence
(direct immunofluorescence). (f) Subendothelial electron dense
deposits (arrow) were present by electron microscopy (original
magnification × 12,000).
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had intraluminal deposits (4 of them had corresponding
‘pseudothrombi’ by light microsocopy). No subepithelial
‘humps’ were identified in any case. Ten cases had deposits of
the immune complex type while 3 cases had deposits with a
microtubular substructure. One case (#7) showed endocapil-
lary aggregates of dense needle-shaped crystalline deposits
that could be mistaken for fibrin tactoids or hyaline thrombi.
Another case (#1) had a mixture of granular and vaguely
fibrillar deposits. With regards to the 2 cases of cryoglobu-
linemic GN, the deposits on electron microscopy in one of
them (#10) were composed of long microtubules with a mean
diameter of 20 nm and parallel arrangement. In the other one
(#12), most of the deposits were granular but few show ill-
defined fibrillar substructure. Some of the intraglomerular
infiltrating macrophages in this case contained large needle-
shaped crystalline inclusions.
To determine whether the ultrastructural findings can
predict whether paraffin IF will show monoclonal deposits or
not in patients with clinical evidence of monoclonal
gammopathy and renal biopsy findings that would have been
consistent with C3 GN based on frozen IF only, we compared
the ultrastructural findings of seven cases of true C3 GN
with monoclonal gammopathy (without masked monoclonal
deposits) versus four cases of MPGN with masked
monoclonal deposits and staining for C3 only on frozen
tissue from the Mayo cohort. As evident from the
data in Supplementary Table S1 online, subepithelial ‘humps’,
intramembranous deposits, or deposits with only mild
electron density, seen in 43, 57, and 29% cases of true C3
GN with monoclonal gammopathy, respectively, were not
present in any case of MPGN with masked monoclonal
deposits, while organized deposits were only seen in MPGN
with masked monoclonal deposits.
Follow-up data was available in 10 patients with a mean
follow-up of 12.2 months (2–27 months). The medications
used in the treatment of each patient are listed in Table 1.
Most of these patients were treated with a therapy directed
against the underlying hematological neoplasia, if present. At
follow-up, 2 (20%) had partial remissions, 6 (60%) had
persistent renal dysfunction, and 1 patient progressed to
end-stage renal disease. The remaining patient had normal-
ization of serum creatinine but follow-up 24-h urinary
protein collection was not available.
DISCUSSION
MPGN is a pattern of glomerular injury recognized on kidney
biopsy when glomeruli show mesangial expansion and
basement membrane duplication by light microscopy.
Traditionally, MPGN has been divided into three categories
based on the appearance and location of the immune deposits
by electron microscopy (types 1, 2, and 3). More recently, a
shift has been made toward a pathogenesis-based classifica-
tion system based on the pattern of staining by IF.6,7
Specifically, biopsies that show the light and electron
microscopic findings of MPGN are now categorized as C3
glomerulopathy when there is C3-only or dominant staining
IgG
Kappa
Lambda
Figure 2 |Renal biopsy findings in patient #12 who had
histological features on light microscopy and electron
microscopy (EM) compatible with cryoglobulinemic
glomerulonephritis. (a) A glomerulus on silver stain shows lobular
accentuation due to mesangial hypercellularity and sclerosis. There is
segmental duplication of the glomerular basement membrane
(arrows) with associated cellular interposition (original magnification
× 400). (b) A glomerulus on trichrome stain shows numerous
intracapillary macrophages. A large subendothelial immune deposit is
also seen (arrow) (original magnification × 600). (c) On EM, large
subendothelial and mesangial electron dense deposits are seen.
Glomerular peripheral capillaries are occluded by infiltrating
monocytes/macrophages (original magnification × 3100). (d) A higher
magnification image highlighting the large electron dense deposits
in the subendothelial space that severely narrow the glomerular
capillary lumen. A macrophage with intracellular phagocytized
deposits and large phagolysosomes is seen (original magnification
× 7830). Panels (e–g) show bright glomerular capillary wall and
mesangial positivity for immunoglobulin G (IgG) (e) and kappa (f) with
negative staining for lambda (g) by immunofluorescence on paraffin
tissue after pronase digestion, corresponding to a monoclonal IgG
kappa on serum immunofixation. The glomerular deposits were
negative for IgG, IgA, C3, C1q, kappa, and lambda by routine
immunofluorescence on frozen tissue (not shown) (original
magnification × 400 for panels (e–g)).
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as identified by IF. This is an important distinction, as this
designation implies a unique pathogenesis in which the
glomerular disease is driven by abnormalities of the
alternative complement cascade. ‘C3 GN with monoclonal
gammopathy’ is a subtype of C3 glomerulopathy character-
ized by C3 deposition in the glomeruli with little to no Ig in
the setting of a monoclonal gammopathy.1 The paraprotein in
these cases is thought to cause GN indirectly through
interacting with complement regulatory proteins leading to
overactivation of the alternative complement pathway.8,9
However, based on the findings in this study, it is likely that
at least some of these cases are caused by paraprotein
deposition in the glomeruli resulting in injury. The under-
lying pathogenic driver of this disease is the presence of a
clonal plasma cell or B cell population in most cases, and it is
therefore best considered a hematological disorder-associated
GN as far as treatment is concerned.
We strongly recommend performing paraffin IF in all
patients with clinical evidence of monoclonal gammopathy in
whom kidney biopsy shows C3 GN or MPGN with negative IF
findings (including cases with light and electron microscopic
features of cryoglobulinemic GN), as this technique unmasks
glomerular monoclonal deposits in about a third of these
patients (see Results). This would provide the treating
nephrologists and/or hematologists compelling evidence that
the monoclonal protein is the cause of GN and would justify
treating with chemotherapy, which can be toxic. This is an
important point as the hematological disorder in these patients
is frequently a low-grade lymphoproliferative disorder (present
in 9 of the 16 patients in our series) in whom chemotherapy
would not be given unless MPGN could be proven to be a
complication of the underlying hematological disorder.1 In
these patients, paraffin IF establishes the diagnosis of
monoclonal gammopathy of renal significance. Monoclonal
gammopathy of renal significance is a term that was recently
introduced by the International Kidney and Monoclonal
Gammopathy Research Group in order to distinguish mono-
clonal gammopathies associated with severe renal complica-
tions due to deposition of monoclonal proteins in the kidney
from benign ‘monoclonal gammopathy of undetermined
significance’, which cannot lead to end-organ damage.1,2
We found that the ultrastructural findings can help
distinguishing MPGN with masked monoclonal deposits
from true C3 GN with monoclonal gammopathy. The
presence of subepithelial ‘humps’, intramembranous deposits,
or deposits with only mild electron density favor true C3 GN
with monoclonal gammopathy. Conversely, the absence of
these findings or the presence of organized deposits (the latter
being exceedingly rare in true C3 GN) favor MPGN with
masked monoclonal deposits. However, as we only studied a
small number of these cases and until larger studies become
available, we still recommend performing paraffin IF in every
case of ‘C3 GN with monoclonal gammopathy’ regardless of
the ultrastructural appearance and location of deposits. Of
note, in this study we only evaluated C3 GN associated with
monoclonal gammopathy; we do not know if these
distinguishing ultrastructural findings can predict whether
paraffin IF will show Ig deposits or not in patients with C3
GN without monoclonal gammopathy.
Interestingly, in contrast to C3 GN, none of the six cases of
DDD associated with monoclonal gammopathy that we tested
by paraffin IF showed unmasked monoclonal deposits.
These preliminary data suggest that paraffin IF may not be
indicated in cases of DDD and support a different pathome-
chanism of glomerular injury in DDD associated with
monoclonal gammopathy than in C3 GN with monoclonal
gammopathy.10
We currently do not know why some Igs show false
negative staining by routine IF. This phenomenon was first
identified in the setting of light chain proximal tubulopathy
with crystal formation in which the crystals require paraffin IF
to uncover the positive light chain restriction.11,12 A previous
report described a case of MPGN in which masked IgG kappa
deposits were uncovered by laser microdissection–mass
spectrometry.13 Considering the fact that up to 41% of
MGPN cases have an abnormal serum protein electrophoresis
in one study,14 it is possible that many of these cases represent
previously unrecognized paraprotein-associated GN. Finally,
membranous-like glomerulopathy with masked IgG kappa
deposits is a glomerulopathy most commonly seen in young
females that also shows false negative staining by routine IF.4
It is interesting that all cases with masked Igs described thus
far involve a monotypic Ig molecule. Apparently there are
qualities of the monoclonal Igs that contribute to the negative
staining by routine IF. Perhaps these proteins have a tertiary
or quaternary structure that does not allow binding to the
target epitope by the antibodies employed and a retrieval
technique (such as protease digestion) is necessary to uncover
the antigenic epitopes. Alternatively, it is possible that the
proteins of interest are washed off from the slide during the
routine IF staining procedure due to a charge–charge
interaction with the slide while the proteins are held in place
on paraffin IF due to formalin-induced cross linking. It is also
possible that the higher antibody concentration used in
paraffin IF might have a role in detection by this modality.
Regardless of what underlies this phenomenon, there is
compelling evidence that it exists and that it may be a
potential pitfall for misdiagnosis if a high index of suspicion is
not maintained.
This finding of ‘masked’ deposits is a rare phenomenon
and paraffin IF is certainly not warranted in the vast majority
of cases. We recently published our experience with this
technique over a 9-month period at Nephropath.5 During this
period, 2% of the 4969 native kidney biopsies were evaluated
by paraffin IF for masked deposits. Out of a total of 97 cases
evaluated, paraffin IF was useful or had a significant
contribution in identifying masked deposits in 22 cases
(23%). We find that paraffin IF is often useful when the
findings by routine IF do not match either the clinical
scenario or electron microscopic findings. In this series, a
masked deposit was uncovered in 36% of Mayo cases that
initially showed C3 GN with monoclonal gammopathy. The
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Nephropath cases show that, in adults with MPGN and C3-
only staining on routine IF, there were equal numbers of cases
of C3 GN and MPGN with masked Ig deposits. Because of the
high frequency of masked deposits in C3 GN in this biopsy
series and others,4 it is our opinion that C3 GN in adults
should be considered a diagnosis of exclusion only after
masked deposits have been excluded by paraffin IF.
Although paraffin IF is a useful technique in the renal
pathology laboratory, there are inherent pitfalls to be aware of
with this procedure. One example is the positive staining of
intraluminal serum that could lead to a false positive
diagnosis if care is not taken to determine the exact location
of the deposits. Therefore, it should not be interpreted as
positive unless staining can be identified along the capillary
walls and within the mesangium (or in the distribution of
‘pseudothrombi’) with corresponding deposits by electron
microscopy. Luminal staining within the capillary loops in
cases lacking intracapillary immune deposits by light micro-
scopy or electron microcopy should be regarded as negative
regardless of the staining pattern. One should also be aware of
the low sensitivity of this technique for the detection of linear
IgG staining in antiglomerular basement membrane disease
and the staining intensity is generally weaker than routine IF
(occasionally falsely negative) in cases of idiopathic membra-
nous nephropathy and IgA nephropathy.12 Finally, the
technique we are describing is based on formalin fixation;
performance of this assay has not been tested with non-
formalin-based fixatives.
We provide the first clinicopathological description of cases
with an MPGN pattern of GN on biopsy with masked
monotypic Ig deposits. This combination of findings is
frequently associated with the presence of an underlying
hematological disorder. A high index of suspicion is necessary
to avoid misdiagnosis in these cases, as many would have been
mistakenly diagnosed as C3 glomerulopathy or unclassified
MPGN in the past. Paraffin IF is necessary to identify the Ig
component and uncover the true nature of these deposits,
avoiding misdiagnosis. It is important to identify the ‘masked’
Ig as this finding frequently informs our understanding of the
true pathogenesis of the patient’s disease. As these cases are best
considered a paraprotein-associated glomerulopathy, treatment
directed against the underlying clonal hematological process is
likely warranted to treat the GN.
MATERIALS AND METHODS
All cases were processed by light, IF, and electron microscopy using
routine techniques described below. All data were collected
according to protocols approved by each institution’s internal
review board.
Light microscopy
Kidney biopsies were fixed in buffered formalin, dehydrated in
graded alcohols, and embedded in paraffin using standard
techniques. Serial 3-μm-thick sections were cut and treated with
hematoxylin and eosin, Jones methenamine silver, Masson tri-
chrome, and periodic acid–Schiff reagent.
Immunofluorescence
For routine IF, samples were transported in Michel’s media, washed
in buffer, and frozen in a cryostat. Sections, cut at 3–5 μm, were
rinsed in buffer, incubated with fluorescein-tagged polyclonal
rabbit anti-human antibodies to IgG, IgA, IgM, C3, C4, C1q,
fibrinogen, and κ-, and λ-light chains (all from Dako, Carpenteria,
CA) for 1 h, and rinsed, and a coverslip was applied using aqueous
mounting media.
Paraffin IF was performed at the Mayo Clinic according to the
protocol previously described by Nasr et al.12 and at Nephropath
according to the protocol described by Messias et al.5 Three-micron
sections were cut from the paraffin-embedded blocks onto
organosilane-coated slides. The sections were deparaffinized in
xylene for 10 min followed by an alcohol gradient. They were then
washed in distilled water and rinsed with buffer. Proteinase K (Dako)
or pronase (Sigma-Aldrich, St Louis, MO) was applied for 20 min.
The sections were then rinsed in buffer, reacted with fluorescein-
tagged polyclonal rabbit anti-human antibodies to IgG, IgA, IgM, κ-,
and λ-light chains (all from Dako), and rinsed and a coverslip was
applied using aqueous mounting media. The results for both
traditional IF and paraffin IF were graded on a scale of 0–3 by
trained renal pathologists. Supplementary Tables S2 and S3 online
detail the protocol for paraffin IF used currently at the Mayo Clinic
and Nephropath.
Electron microscopy
Renal biopsy tissue was embedded in epon/araldite resin. Sections
1-μm thick were cut using an ultramicrotome, stained with toluidine
blue (Electron Micrscopy Sciences, Hartfield, PA) and examined with
a light microscope. Thin sections were examined in an electron
microscope.
Clinical definitions
The following definitions were applied: hematuria, 45 red blood
cells per high-power field; nephrotic syndrome, 24-h urine protein
43.5 g/day, peripheral edema, and hypoalbuminemia (o3.5 g/dl);
and renal insufficiency, serum creatinine 41.2 mg/dl. Proteinuria is
reported in g/day, when available, or urine protein/creatinine ratio.
The following definitions were applied for the purpose of outcome
analysis and are similar to those we used previously15: complete
remission, remission of proteinuria to o500mg/day with normal
renal function; partial remission, reduction in proteinuria by at least
50% and to o2 g/day with stable renal function (no more than a
20% increase in serum Cr); persistent kidney dysfunction, failure to
meet criteria for complete or partial remission but not reaching end-
stage kidney disease (incudes patients with unremitting proteinuria
or progressive chronic kidney disease); and end-stage kidney disease,
requiring renal replacement therapy.
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SUPPLEMENTARY MATERIAL
Table S1. Ultrastructural findings in C3 GN with monoclonal
gammopathy (without masked monoclonal deposits) vs. MPGN
with masked monoclonal deposits and staining for C3 only on
frozen tissue.
Table S2. Paraffin immunofluorescence staining procedure from
Mayo Clinic.
Table S3. Paraffin immunofluorescence staining procedure from
Nephropath.
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Figure S1. Renal biopsy findings in patient #10 who had histologic
features on LM and EM compatible with cryoglobulinemic
glomerulonephritis.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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